
    
      Twenty patients with pseudophakic lenses, treated with ILUVIEN, were investigated to evaluate
      functional and anatomical characteristics and outcomes (visual acuity [VA; ETDRS letters
      score], central macular thickness [CMT] and intraocular pressure [IOP]) at baseline, weeks
      2-4 and months 3, 6 and 12 months.
    
  